Novadip Biosciences Raises Additional Eur 40 Million Bringing Total Company Funding To Eur 88 Million
Amount Raised
€40 Million
Round Type
Funding Round
BelgiumBiotechnologyHealth CareMedicalTherapeuticsDescription
Novadip Biosciences (“Novadip” or “the Company”), a clinical-stage biopharmaceutical company developing a new class of regenerative tissue products to accelerate healing of large bone defects and injuries in a single treatment, today announced that it has raised an additional EUR 40 million in a Series B equity round and non-dilutive funding. The funding will accelerate the clinical development of two of Novadip’s investigational adipose stem cell (ASC)-derived tissue regeneration products: NVD-X3, an allogeneic therapeutic that can provide accelerated, durable bone union in spinal fusion procedures and non-healing fractures, and NVD-003, an autologous bone engraftment product designed to provide a single treatment cure for patients with critical size bone defects such as congenital pseudoarthrosis of the tibia (CPT).
Quick answer
Novadip Biosciences raised €40 Million in a Funding Round round, dated November 4, 2022. Novadip Biosciences is based in Belgium.
- How much did Novadip Biosciences raise?
- Novadip Biosciences raised €40 Million in a Funding Round round on November 4, 2022.
- What does Novadip Biosciences do?
- Novadip Biosciences is a biopharmaceutical company founded to design, develop and bring to the market innovative stem cell-based therapies for regenerative medicine.
- Where is Novadip Biosciences based and how big is it?
- Novadip Biosciences is based in Belgium. Fundz records about 58 employees.
- Who are the decision-makers at Novadip Biosciences?
- Fundz holds 2 contacts at Novadip Biosciences, including the Corporate Vice President Quality. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Therapeutics around the same time
Companies in the same sectors as Novadip Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Renibus Therapeutics raised $33M (Funding Round) on November 14, 2022.
- NRx Pharmaceuticals raised $11M (Debt Financing) on November 7, 2022.
- Qnovia raised $17M (Series A) on September 28, 2022.
- Gamida Cell raised $25M (Funding Round) on September 28, 2022.
- Fountain Life raised $15M on December 15, 2022.
- Gallant raised $25M on December 15, 2022.
Who to call at Novadip Biosciences, and when
A new round usually means Novadip Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Novadip Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Novadip Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Novadip Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Novadip Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Novadip Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.